Legal & General Group
BTAI icon

Legal & General Group’s BioXcel Therapeutics BTAI Stock Holding History

Legal & General Group’s Portfolio BTAI Stock Details BTAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-126
Closed -$5.68K – 3429
2024
Q1 		$5.68K Sell
126
-62
-33% -$2.96K ﹤0.01% 3285
2023
Q4 		$8.91K Sell
188
-648
-78% -$36K ﹤0.01% 3257
2023
Q3 		$33.9K Sell
836
-317
-27% -$32K ﹤0.01% 2908
2023
Q2 		$123K Buy
1,153
+535
+87% +$178K ﹤0.01% 2813
2023
Q1 		$184K Buy
618
+13
+2% +$5.55K ﹤0.01% 2617
2022
Q4 		$208K Buy
605
+42
+7% +$10.2K ﹤0.01% 2593
2022
Q3 		$107K Buy
563
+19
+3% +$4.41K ﹤0.01% 2798
2022
Q2 		$114K Buy
544
+19
+4% +$4K ﹤0.01% 2819
2022
Q1 		$176K Buy
525
+5
+1% +$1.45K ﹤0.01% 2711
2021
Q4 		$169K Hold
520
– – ﹤0.01% 2777
2021
Q3 		$252K Buy
520
+248
+91% +$109K ﹤0.01% 2613
2021
Q2 		$127K Buy
272
+12
+5% +$6.54K ﹤0.01% 2664
2021
Q1 		$179K Sell
260
-4
-2% -$3.22K ﹤0.01% 2476
2020
Q4 		$195K Buy
264
+149
+130% +$116K ﹤0.01% 2428
2020
Q3 		$80K Sell
115
-21
-15% -$15.8K ﹤0.01% 2548
2020
Q2 		$116K Buy
136
+70
+106% +$45.6K ﹤0.01% 2488
2020
Q1 		$24K Sell
66
-11
-14% -$3.95K ﹤0.01% 2847
2019
Q4 		$18K Buy
77
+14
+22% +$1.41K ﹤0.01% 3209
2019
Q3 		$7K Hold
63
– – ﹤0.01% 3302
2019
Q2 		$11K Buy
+63
New +$10.7K ﹤0.01% 3341

Other funds holding BTAI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Legal & General Group's BTAI Position: Q2 2024 in Review

Legal & General Group sold out of BioXcel Therapeutics (BTAI) in Q2 2024, closing a stake of 126 shares — an estimated $5.68K sold.

Legal & General Group first reported a position in BTAI in Q2 2019 and held it in 20 quarters. The position peaked at $252K in Q3 2021. 74 funds tracked by Wall St. Rank hold BTAI as of Q2 2024.

  • Legal & General Group reported no remaining BioXcel Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Legal & General Group sold 126 BioXcel Therapeutics shares in Q2 2024, an estimated $5.68K.
  • Legal & General Group first reported a position in BioXcel Therapeutics in Q2 2019 and held it in 20 quarters.
  • Legal & General Group's BioXcel Therapeutics position peaked at $252K in Q3 2021.
  • 74 funds tracked by Wall St. Rank held BioXcel Therapeutics as of Q2 2024.

Based on Legal & General Group's 13F filing for Q2 2024, filed 14 Aug 2024.